350 related articles for article (PubMed ID: 16462492)
1. Bone morphogenetic protein gene therapy using a fibrin scaffold for a rabbit spinal-fusion experiment.
Lee TC; Ho JT; Hung KS; Chen WF; Chung YH; Yang YL
Neurosurgery; 2006 Feb; 58(2):373-80; discussion 373-80. PubMed ID: 16462492
[TBL] [Abstract][Full Text] [Related]
2. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
[TBL] [Abstract][Full Text] [Related]
3. An in vitro and in vivo analysis of fibrin glue use to control bone morphogenetic protein diffusion and bone morphogenetic protein-stimulated bone growth.
Patel VV; Zhao L; Wong P; Pradhan BB; Bae HW; Kanim L; Delamarter RB
Spine J; 2006; 6(4):397-403; discussion 404. PubMed ID: 16825045
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene.
Cheng SL; Lou J; Wright NM; Lai CF; Avioli LV; Riew KD
Calcif Tissue Int; 2001 Feb; 68(2):87-94. PubMed ID: 11310352
[TBL] [Abstract][Full Text] [Related]
5. Comparison of lentiviral and adenoviral gene therapy for spinal fusion in rats.
Miyazaki M; Sugiyama O; Zou J; Yoon SH; Wei F; Morishita Y; Sintuu C; Virk MS; Lieberman JR; Wang JC
Spine (Phila Pa 1976); 2008 Jun; 33(13):1410-7. PubMed ID: 18475244
[TBL] [Abstract][Full Text] [Related]
6. [Experimental study on spinal fusion induced by hBMP-4 gene modified tissue engineered bone].
Zheng ZM; Dong ZY; Kuang GM; Chen H; Lü Y; Zhang KB; Liu H; Li FB
Zhonghua Wai Ke Za Zhi; 2009 Feb; 47(3):197-201. PubMed ID: 19563074
[TBL] [Abstract][Full Text] [Related]
7. A porcine collagen-derived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats.
Miyazaki M; Morishita Y; He W; Hu M; Sintuu C; Hymanson HJ; Falakassa J; Tsumura H; Wang JC
Spine J; 2009; 9(1):22-30. PubMed ID: 18805060
[TBL] [Abstract][Full Text] [Related]
8. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion.
Akamaru T; Suh D; Boden SD; Kim HS; Minamide A; Louis-Ugbo J
Spine (Phila Pa 1976); 2003 Mar; 28(5):429-34. PubMed ID: 12616152
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of insoluble bone gelatin as a carrier for enhancement of osteogenic protein-1-induced intertransverse process lumbar fusion in a rabbit model.
Yao G; Qian Y; Chen J; Fan Y; Stoffel K; Yao F; Xu J; Zheng MH
Spine (Phila Pa 1976); 2008 Aug; 33(18):1935-42. PubMed ID: 18708925
[TBL] [Abstract][Full Text] [Related]
10. The adjunctive effect of a binding peptide on bone morphogenetic protein enhanced bone healing in a rodent model of spinal fusion.
Alanay A; Chen C; Lee S; Murray SS; Brochmann EJ; Miyazaki M; Napoli A; Wang JC
Spine (Phila Pa 1976); 2008 Jul; 33(16):1709-13. PubMed ID: 18580546
[TBL] [Abstract][Full Text] [Related]
11. rhBMP-2 enhancement of posterolateral spinal fusion in a rabbit model in the presence of concurrently administered doxorubicin.
Singh K; Smucker JD; Ugbo JL; Tortolani PJ; Tsai L; Fei Q; Kuh S; Rumi M; Heller JG; Boden SD; Yoon ST
Spine J; 2007; 7(3):326-31. PubMed ID: 17482116
[TBL] [Abstract][Full Text] [Related]
12. Enhancing effects of a prostaglandin EP4 receptor agonist on recombinant human bone morphogenetic protein-2 mediated spine fusion in a rabbit model.
Namikawa T; Terai H; Hoshino M; Kato M; Toyoda H; Yano K; Nakamura H; Takaoka K
Spine (Phila Pa 1976); 2007 Oct; 32(21):2294-9. PubMed ID: 17906568
[TBL] [Abstract][Full Text] [Related]
13. The Marshall R. Urist Young Investigator Award. Gene expression during autograft lumbar spine fusion and the effect of bone morphogenetic protein 2.
Morone MA; Boden SD; Hair G; Martin GJ; Racine M; Titus L; Hutton WC
Clin Orthop Relat Res; 1998 Jun; (351):252-65. PubMed ID: 9646769
[TBL] [Abstract][Full Text] [Related]
14. rhBMP-6 stimulated osteoprogenitor cells enhance posterolateral spinal fusion in the New Zealand white rabbit.
Valdes M; Moore DC; Palumbo M; Lucas PR; Robertson A; Appel J; Ehrlich MG; Keeping HS
Spine J; 2007; 7(3):318-25. PubMed ID: 17482115
[TBL] [Abstract][Full Text] [Related]
15. Platelet-rich plasma and fibrin as delivery systems for recombinant human bone morphogenetic protein-2.
Jung RE; Schmoekel HG; Zwahlen R; Kokovic V; Hammerle CH; Weber FE
Clin Oral Implants Res; 2005 Dec; 16(6):676-82. PubMed ID: 16307574
[TBL] [Abstract][Full Text] [Related]
16. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate.
Suh DY; Boden SD; Louis-Ugbo J; Mayr M; Murakami H; Kim HS; Minamide A; Hutton WC
Spine (Phila Pa 1976); 2002 Feb; 27(4):353-60. PubMed ID: 11840099
[TBL] [Abstract][Full Text] [Related]
17. [Effects of calcitonin on the pathology of spinal fusion in rabbit models].
Fan Y; Wu ZH; Zhang JG; Liu Y; Qiu GX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):574-8. PubMed ID: 16995317
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
Dimar JR; Glassman SD; Burkus KJ; Carreon LY
Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
[TBL] [Abstract][Full Text] [Related]
19. Combination of porous hydroxyapatite and cationic liposomes as a vector for BMP-2 gene therapy.
Ono I; Yamashita T; Jin HY; Ito Y; Hamada H; Akasaka Y; Nakasu M; Ogawa T; Jimbow K
Biomaterials; 2004 Aug; 25(19):4709-18. PubMed ID: 15120517
[TBL] [Abstract][Full Text] [Related]
20. Autograft containment in posterolateral spine fusion.
Rao RD; Bagaria V; Gourab K; Haworth ST; Shidham VB; Cooley BC
Spine J; 2008; 8(4):563-9. PubMed ID: 17923443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
